FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 50 mg/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 50 mg/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 50 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 50 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 25 mg/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 50 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 50 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 50 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 25 mg/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Epinephrine; Lidocaine Hydrochloride | 30 ug/3 mL; 15 mg/3 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Acetaminophen | 100 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1500 ug/30 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1000 ug/50 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1000 ug/20 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1.25 mg/250 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 2.5 mg/50 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 2 mg/100 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 100 ug/2 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 2.5 mg/250 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1 mg/100 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1500 ug/30 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 250 ug/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 2750 ug/55 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 2 mg/100 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 10 ug/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1000 ug/20 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 2.5 mg/50 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1500 ug/30 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 250 ug/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1500 ug/30 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 2.5 mg/250 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 100 ug/2 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1 mg/100 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1 mg/100 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Glycopyrrolate | 1 mg/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 30000 U/1000 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 6 mg/30 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 6 mg/30 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 30 mg/30 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 25 mg/50 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 30 mg/30 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 6 mg/30 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ketamine Hydrochloride | 50 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 |